Summit Place Financial Advisors LLC Acquires 1,380 Shares of GE HealthCare Technologies Inc. $GEHC

Summit Place Financial Advisors LLC raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 37,298 shares of the company’s stock after acquiring an additional 1,380 shares during the quarter. Summit Place Financial Advisors LLC’s holdings in GE HealthCare Technologies were worth $2,763,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Hotchkis & Wiley Capital Management LLC boosted its stake in GE HealthCare Technologies by 3.2% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock valued at $464,226,000 after acquiring an additional 176,572 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after acquiring an additional 1,711,963 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of GE HealthCare Technologies by 3.3% during the first quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock worth $398,975,000 after purchasing an additional 157,839 shares in the last quarter. Canada Pension Plan Investment Board boosted its position in shares of GE HealthCare Technologies by 15.2% during the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after purchasing an additional 409,636 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of GE HealthCare Technologies by 3.7% during the first quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company’s stock worth $247,708,000 after purchasing an additional 109,858 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Down 4.3%

GEHC opened at $71.01 on Friday. The stock has a market capitalization of $32.42 billion, a P/E ratio of 14.55, a P/E/G ratio of 2.84 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The firm’s fifty day simple moving average is $74.31 and its 200 day simple moving average is $72.34. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm’s revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s payout ratio is currently 2.87%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on GEHC shares. Weiss Ratings reissued a “hold (c)” rating on shares of GE HealthCare Technologies in a research report on Saturday, September 27th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Morgan Stanley set a $74.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, September 18th. Citigroup cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $93.00 to $83.00 in a research report on Tuesday. Finally, BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Six research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $85.78.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.